Description
Class C07J : STEROIDS
Subclass 13/00: Normal steroids containing carbon, hydrogen, halogen, or oxygen, having a carbon-to-carbon double bond from or to position 17
C07J 13/00
Sub-Class
Stats
- 77 US PATENTS IN FORCE
- 7 US APPLICATIONS PENDING
- 16 Total Patent Owners
- 197 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12201640 | 19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereof | Dec 23, 21 | Jan 21, 25 | SAGE THERAPEUTICS, INC. |
| 12180248 | Compositions and methods for treating CNS disorders | Feb 16, 23 | Dec 31, 24 | SAGE THERAPEUTICS, INC. |
| 12129276 | Oxysterols and methods of use thereof | Mar 02, 23 | Oct 29, 24 | SAGE THERAPEUTICS, INC. |
| 12071453 | Neuroactive steroids, compositions, and uses thereof | Sep 26, 22 | Aug 27, 24 | SAGE THERAPEUTICS, INC. |
| 12065463 | Compositions and methods for treating CNS disorders | Oct 24, 22 | Aug 20, 24 | SAGE THERAPEUTICS, INC. |
| 11912737 | 19-nor neuroactive steroids and methods of use thereof | Oct 09, 20 | Feb 27, 24 | Sage Therpeutics, Inc. |
| 11905309 | Neuroactive steroids and methods of use thereof | Jul 21, 21 | Feb 20, 24 | SAGE THERAPEUTICS, INC. |
| 11858946 | Small molecules active against gram-negative bacteria | May 03, 21 | Jan 02, 24 | The Board of Trustees of the University of Illinois |
| 11780875 | Neuroactive steroids, compositions, and uses thereof | Sep 13, 21 | Oct 10, 23 | SAGE THERAPEUTICS, INC. |
| 11732000 | Oxysterols and methods of use thereof | Aug 06, 21 | Aug 22, 23 | SAGE THERAPEUTICS, INC. |
| 11542297 | Compositions and methods for treating CNS disorders | Mar 15, 22 | Jan 03, 23 | SAGE THERAPEUTICS, INC. |
| 11530237 | Compositions and methods for treating CNS disorders | Jan 21, 20 | Dec 20, 22 | SAGE THERAPEUTICS, INC. |
| 11498940 | Neuroactive steroids, compositions, and uses thereof | Apr 08, 20 | Nov 15, 22 | SAGE THERAPEUTICS, INC. |
| 11479577 | Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid | Feb 26, 21 | Oct 25, 22 | NZP UK Limited |
| 11344563 | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof | Jul 10, 19 | May 31, 22 | SAGE THERAPEUTICS, INC. |
| 11261211 | 19-NOR neuroactive steroids and methods of use thereof | Jun 13, 19 | Mar 01, 22 | SAGE THERAPEUTICS, INC. |
| 11241446 | 19-nor C3, 3-disubstituted C21-N-pyrazolyl steroids and methods of use thereof | May 31, 19 | Feb 08, 22 | SAGE THERAPEUTICS, INC. |
| 11149057 | Neuroactive steroids, compositions, and uses thereof | Jul 09, 20 | Oct 19, 21 | SAGE THERAPEUTICS, INC. |
| 11147877 | Compositions and methods for treating CNS disorders | Aug 20, 19 | Oct 19, 21 | SAGE THERAPEUTICS, INC. |
| 11124538 | Neuroactive steroids, compositions, and uses thereof | Apr 30, 19 | Sep 21, 21 | SAGE THERAPEUTICS, INC. |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0409,576 | -ent-19-norprogesterone, compositions and uses thereof to treat traumatic brain injury (TBI), including concussions- | May 30, 23 | Dec 12, 24 | Oragenics, Inc |
| 2024/0368,213 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | Jun 12, 24 | Nov 07, 24 | Not available |
| 2024/0287,125 | NEUROACTIVE STEROIDS AND METHODS OF USE THEREOF | Jan 05, 24 | Aug 29, 24 | Not available |
| 2024/0109,934 | ANTIBIOTICS WITH IMPROVED DRUG RESISTANCE PROFILE | Jan 13, 22 | Apr 04, 24 | The Board of Trustees of the University of Illinois |
| 2022/0169,672 | COMPOUNDS FOR TARGETED THERAPIES OF CASTRATION RESISTANT PROSTATE CANCER | Feb 28, 20 | Jun 02, 22 | Not available |
| 2017/0283,455 | STABLE TOPICAL PHAMACEUTICAL COMPOSITIONS OF HALOBETASOL PROPIONATE | Jun 09, 17 | Oct 05, 17 | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
| 2017/0210,775 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | Apr 10, 17 | Jul 27, 17 | JINA PHARMACEUTICALS, INC. |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 32 Months (last 2 years Issuances)
- 32 Months (last 5 years Issuances)